An investigational in‑body base‑editing medicine called VERVE‑102 produced dose‑dependent, sustained reductions in PCSK9 and LDL cholesterol in a Phase 1b…
CAR T-cell therapy has changed the treatment landscape for some blood cancers by reprogramming a patient’s own immune cells to…
A long-acting antibody is changing how doctors protect babies from respiratory syncytial virus, offering the youngest patients direct protection during…
The first FDA-approved cellular therapy for a solid tumor turns immune cells taken from a patient’s melanoma into a one-time…
A small but remarkable clinical advance shows how a patient’s own cells might one day be reprogrammed into insulin-producing tissue—while…
A blood test that detects Alzheimer’s-related proteins has received FDA clearance, offering doctors a simpler way to help identify the…
The cell therapy that transformed treatment for some blood cancers is now being tested in lupus, systemic sclerosis, and other…
Early clinical studies are testing whether a repaired gene can restore the inner-ear machinery that some children never had. The…
A new long-acting medicine is giving HIV prevention a different rhythm: instead of remembering a pill every day, eligible people…
After decades of research, two WHO-recommended malaria vaccines are beginning to reach children in the places where the disease remains…
The first FDA-approved CRISPR medicine is not a laboratory curiosity. It is a painstaking, personalized treatment designed to help people…